Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-99-004112
Filing Date
1999-08-16
Accepted
1999-08-16 00:00:00
Documents
6
Period of Report
1999-06-30

Document Format Files

Seq Description Document Type Size
1 GELTEX PHARMACEUTICALS, INC. 10-Q 41361
2 AMENDED AND RESTATED 1992 EQUITY INCENTIVE PLAN EX-10.1 23086
3 AMENDED & RESTATED 1995 DIRECTOR STOCK OPTION PLAN EX-10.2 11739
4 AGREEMENT AND PLAN OF MERGER DATED 13-AUG-1999 EX-10.3 285280
5 PURCHASE AND SALE AGREEMENT DATED 26-JUL-1999 EX-10.4 53976
6 FINANCIAL DATA SCHEDULE EX-27.1 2133
  Complete submission text file 0000950135-99-004112.txt   419585
Mailing Address 303 BEAR HILL RD WALTHAM MA 02154
Business Address 303 BEAR HILL RD WALTHAM MA 02154 781-290-5888
GELTEX PHARMACEUTICALS INC (Filer) CIK: 0001001425 (see all company filings)

EIN.: 043136767 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26872 | Film No.: 99692802
SIC: 2834 Pharmaceutical Preparations